AT, P., HC, H., MB, P., R, P., & A, J. (2023). The impact of adopting low-molecular-weight heparin in place of aspirin as routine thromboprophylaxis for patients with hip fracture. Postgraduate medical journal, 99(1172), 582. https://doi.org/10.1136/postgradmedj-2022-141628
Chicago Style (17th ed.) CitationAT, Poacher, Hoskins HC, Protty MB, Pettit R, and Johansen A. "The Impact of Adopting Low-molecular-weight Heparin in Place of Aspirin as Routine Thromboprophylaxis for Patients with Hip Fracture." Postgraduate Medical Journal 99, no. 1172 (2023): 582. https://doi.org/10.1136/postgradmedj-2022-141628.
MLA (9th ed.) CitationAT, Poacher, et al. "The Impact of Adopting Low-molecular-weight Heparin in Place of Aspirin as Routine Thromboprophylaxis for Patients with Hip Fracture." Postgraduate Medical Journal, vol. 99, no. 1172, 2023, p. 582, https://doi.org/10.1136/postgradmedj-2022-141628.